Back to News
Sep 16, 2025 4:00 PM

FDA Flags Eli Lilly's Weight-Loss Drug Video For Misleading Claims

The U.S. Food and Drug Administration (FDA) has determined that a promotional video featuring Zepbound and Mounjaro (tirzepatide), both produced by Eli Lilly And Co. (NYSE:LLY), is false or misleading.

The agency's review found that the video misbrands the drugs by underplaying serious health risks and omitting critical safety information.

LLY shares are advancing steadily. Check the analyst’s take here.

The video, a 42-minute program hosted by Oprah Winfrey, focused on weight-loss treatments and their growing popularity.

It prominently featured Dr. W. Scott Butsch and Dr. Amanda Velazquez, who are paid consultants to drug manufacturers and receive research funding from companies making GLP-1 drugs such as Zepbound and Mounjaro. The video discussed the benefits of these medications but failed to adequately disclose significant risks.

Also Read: